QUIK-CHECK HOME PREGNANCY TEST

K012215 · ACON Laboratories, Inc. · LCX · Aug 7, 2001 · Clinical Chemistry

Device Facts

• Record ID: K012215
• Device Name: QUIK-CHECK HOME PREGNANCY TEST
• Applicant: ACON Laboratories, Inc.
• Product Code: LCX · Clinical Chemistry
• Decision Date: Aug 7, 2001
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 862.1155
• Device Class: Class 2

Intended Use

Quik-Check™ Home Pregnancy is intended for non-professional/Over-The Counter use for the detection of hCG (human Chorionic Gonadotropin) in urine to aid in the determination of pregnancy.

Device Story

Quik-Check™ Home Pregnancy Test is a lateral flow immunoassay for qualitative detection of hCG in urine. Device utilizes capillary action to migrate urine across a membrane containing antibody-hCG-colored conjugates. Presence of hCG at concentrations ≥25 mIU/mL results in a colored line at the 'Test Region'; a 'Control Region' line appears regardless of hCG presence to verify test validity. Intended for home use by lay users; results are interpreted visually by the user. Provides rapid pregnancy status determination to assist in clinical decision-making.

Clinical Evidence

Clinical trial conducted with 117 female participants. Results confirmed the device is suitable for over-the-counter use, with participants successfully understanding labeling, following instructions, and interpreting results.

Technological Characteristics

Lateral flow immunoassay; membrane-based; utilizes antibody-hCG-colored conjugate reagents. Detects hCG concentrations ≥25 mIU/mL. Standardized to WHO Third International Standard. No electronic components or software.

Indications for Use

Indicated for non-professional, over-the-counter use by individuals to detect human Chorionic Gonadotropin (hCG) in urine to aid in the determination of pregnancy.

Regulatory Classification

Identification

A human chorionic gonadotropin (HCG) test system is a device intended for the early detection of pregnancy is intended to measure HCG, a placental hormone, in plasma or urine. A human chorionic goadotropin (HCG) test system is a device intended for any uses other than early detection of pregnancy (such as an aid in the diagnosis, prognosis, and management of treatment of persons with certain tumors or carcinomas) is intended to measure HCG, a placental hormone, in plasma or urine.

Submission Summary (Full Text)

{0}------------------------------------------------

K012215

AUG - 7 2001

## Summary of Safety & Effectiveness

The Quik-Check™ Home Pregnancy Test Device is intended for non-professional/Over-determination of for the Quik-Checker" Home Pregiancy Tost Dones in thCG) in urine to add in the determination of for the identification of numan Chonomic Golladoneyal (no operioral antibody reagents to selectively pregnancy. The test utilizes a collibination of including unine to the test device and observing for the programments regent with the defect elevated levels of ICC. The assay is conceeded of paillary action along the membrate on formation of comments and forma formation of colored lines. The speciment migrates the specific antibody-hCG-colored conjugate and form a colored conjugate. Postive specificals react with the suggests a negative result.
colored line on the "Test Region" of the membrane. Absence of this suggests anegatives of t colored line on the "rest Region" of the membrant." Hosener of the version will always appear regardless of the presence or absence of hCG.

The Quik-Check™ Home Pregnancy test detects hCG concentrations of 25 mU/ml and geater. The test H has been standardized to the World Health Organization Third International Standard. The addition of M.H.H. has been standardized to the World Italin Organization Introdult to negative (0 mIU/ml hCG) and positive (25 mIU/ml hCG) urine showed no cross-reactivity.

Clinical trials using Quik-Check™ Home Pregnancy Test were conducted which included 117 female Chilical thats using Quile-Chevel - Tremaiority of the participants found Quilt-Check™ Home participants. The results of the study showed and they conferstanding the labeling, reading the instructions, or interpreting the results.

The overall results of the clinical trial confirm that Quik-Check™ Home Pregnancy Test is a suitable test for over-the-counter pregnancy testing.

{1}------------------------------------------------

DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three curved lines representing its wings. The eagle is positioned to the right of the text "DEPARTMENT OF HEALTH & HUMAN SERVICES-USA", which is arranged in a circular fashion around the left side of the logo.

Food and Drug Administration 2098 Gaither Road Rockville MD 20850

SEP 1 8 2001

Edward Tung, Ph.D. Regulatory Affairs ACON Laboratories, Inc. 4108 Sorrento Valley Blvd. San Diego, CA 92121

510(k) Number: K012215 Re: Trade/Device Name: Quik-Check™Home Pregnancy Test Regulation Number: 862.1155 Regulatory Class: II Product Code: I .C.X Dated: July 10, 2001 Received: July 16, 2001

Dear Dr. Tung:

This letter replaces and corrects letter dated August 7, 2001. The device name was incorrect. It was spelled Quick-Check. It should be spelled Quik-Check.

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Good Manufacturing Practice for Medical Devices: General (GMP) regulation (21 CFR Part 820) and that, through periodic GMP inspections, the Food and Drug Administration (FDA) will verify such perious on. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal addition, I Drivinal publisher published to your premarket notification submission does not affect reefice. Frease now, ht have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

{2}------------------------------------------------

Page 2 -

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed nredicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and 1 additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at [phone]. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers International and Consumer Assistance at its toll-free number [phone] or [phone] or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".

Sincerely yours,

Steven Sutman

Steven I. Gutman, M.D., M.B.A. Director Division of Clinical Laboratory Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{3}------------------------------------------------

## Indications For Use

510(k) Number:_ ¥012215_______________________________________________________________________________________________________________________________________________________

Device Name: Quik-Check™ Home Pregnancy Test

"Indications For Use" - Quik-Check™ Home Pregnancy is intended for mon-professional/Over-The Counter Quik-Check - Tome Proghancy is more of hCG (human Chorionic Gonadotropin) in urine to aid in the determination of pregnancy.

(Please do not write below this line)

Concurrence of CDRH, Office of Device Evaluation (ODE)

| | Kesia Alexander for Jaan varas |
|-----------------------------------------|--------------------------------|
| (Division Sign-Off) | |
| Division of Clinical Laboratory Devices | |
| 510(k) Number | K012215 |

| Prescription Use | |
|----------------------|---------------------------------------------------------|
| | or (per 21 CFR 801.109) |
| Over-The-Counter Use | <div> <img alt="Checkmark" src="checkmark.png"/> </div> |